Latest AI and machine learning research in bipolar disorder for healthcare professionals.
Major depressive disorder (MDD), bipolar disorder (BP), and schizophrenia (SCZ) involve learning impairments with poorly understood mechanisms. Understanding both the similarities and differences in these mechanisms is important to guide the development of new, targeted interventions. 255 participants diagnosed with MDD (n=54), BP (n=47), SCZ (n=67) or without any diagnoses (CTRL; n=87) performed ...
Advances in computational methods have accelerated the application of machine learning to analyze large complex biological data. By applying machine learning algorithms to neuroimaging data, researchers have estimated the “biological age of the brain” i.e., brain age, and used it as a composite metric for indexing brain health, as opposed to using individual features of the brain extracted from ne...
The current state of mental health treatment for individuals diagnosed with major depressive disorder leaves billions of individuals with first-line t...
The CACNA1C gene encodes the CaV1.2 L-type voltage-gated calcium channel, which plays a crucial role in neuronal signaling. CACNA1C is a risk gene for...
Recent advances in deep brain stimulation (DBS) of the subcallosal cingulate (SCC) show promise in mitigating the symptoms of treatment-resistant depr...
To characterize cell type specific transcriptional changes during human retinal aging and develop machine learning model for cellular age discriminati...
Accurate psychiatric diagnosis and assessment are crucial for effective treatment. However, while current data-driven approaches emphasize diagnostic ...
Preclinical evidence points to disturbances in neural networks in psychosis involving interrelations between dopaminergic-, GABAergic- and glutamaterg...
This study provides a comprehensive medical ecology analysis of gut microbiome alterations in four neuropsychiatric disorders: Alzheimer’s disease (AD...
Major depressive disorder (MDD) remains challenging to treat, with many patients failing to respond adequately to existing therapies. Patients with MD...
Depression is associated with alterations in immuno-metabolic biomarkers, but it remains unclear whether these alterations are limited to specific mar...
Schizophrenia and bipolar disorder are severe mental illnesses that significantly impact quality of life. These disorders are associated with autonomi...
Social media presents a promising avenue for monitoring mental health, yet detecting bipolar disorder (BD) remains significantly underexplored. The co...
To prevent clozapine-induced agranulocytosis (CIA), patients’ white blood cell counts are closely monitored, with treatment stopped if the absolute ne...
Guidance is lacking on choice of first-line antipsychotic for individuals with incident severe mental illness (SMI). Patients may try several before a...
The bidirectional relationship between sleep disturbances and depression presents a serious challenge for digital mental health research and intervent...
Recent technologies for quantifying behavior have revolutionized animal studies in social, cognitive, and pharmacological neurosciences. However, comp...
Despite major depressive disorder (MDD) being the leading cause of disability worldwide, the exact characterization of its neural bases and the develo...
Late-life depression (LLD) is prevalent in older adults and linked to increased disability, mortality, and suicide risk. Insomnia symptoms are conside...
Digital phenotyping, which takes advantage of data continuously gathered from smartphones and wearable devices, offers promising avenues for real-time...